PembrolizumabAcute onset type-1 diabetes mellitus: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1770卷 / 1期

关键词：

D O I：

10.1007/s40278-019-67760-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：325 / 325

相关论文

共 50 条

[1] NivolumabDelayed acute-onset type-1 diabetes mellitus: case report
Reactions Weekly, 2020, 1785 (1) : 389 - 389
[2] PembrolizumabFulminant type-1 diabetes mellitus: case report
Reactions Weekly, 2019, 1761 (1) : 297 - 297
[3] AvelumabFulminant type-1 diabetes mellitus: case report
Reactions Weekly, 2019, 1772 (1) : 67 - 67
[4] AtezolizumabAcute onset type-1 diabetes: case report
Reactions Weekly, 2020, 1789 (1) : 50 - 50
[5] Glycogen hepatopathy in type-1 diabetes mellitus: A case report
Yuvaraj Singh
Susant Gurung
Maya Gogtay
World Journal of Hepatology, 2022, (02) : 471 - 478
[6] NivolumabFulminant type-1 diabetes mellitus and hypophysitis: case report
Reactions Weekly, 2018, 1698 (1) : 260 - 260
[7] DurvalumabThyroid insufficiency and type-1 diabetes mellitus: case report
Reactions Weekly, 2024, 2037 (1) : 164 - 164
[8] Glycogen hepatopathy in type-1 diabetes mellitus: A case report
Singh, Yuvaraj
Gurung, Susant
Gogtay, Maya
WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (02) : 471 - 478
[9] RisperidoneDiabetic ketoacidosis and first report of type-1 diabetes mellitus: case report
Reactions Weekly, 2005, 1050 (1) : 17 - 17
[10] Ipilimumab/nivolumabFulminant type-1 diabetes mellitus and hypophysitis: case report
Reactions Weekly, 2022, 1894 (1) : 192 - 192

← 1 2 3 4 5 →